血小板衍生生长因子在莱维体病的认知波动和幻觉中增加
Priscilla Youssef1, Michelle Chua1, Linnea Andersson2
1School of Medical Sciences, Faculty of Medicine and Health and the Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia.
Parkinsonism & related disorders
|October 18, 2025
概括
血小板衍生生长因子 (PDGF) 信号的升高与勒维体病 (LBD) 中的认知波动和视觉幻觉有关. 这表明PDGF可能会导致LBD患者的这些神经症状.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 医学研究 医学研究
背景情况:
- 列维体病 (LBD) 呈现出常见的精神发作症状,如认知波动和幻觉.
- 这些症状的潜在病理生理学尚未完全理解,但可能涉及神经血管单元功能障碍和大脑血流改变.
研究的目的:
- 调查外围血小板衍生生长因子 (PDGF) 信号与LBD患者认知波动和视觉幻觉的发生之间的关联.
- 探索PDGF信号在神经血管单元中关于LBD症状的作用.
主要方法:
- 分析了LBD患者的血样本,根据症状存在 (认知波动/幻觉) 分层.
- 为了测量PDGF和PDGF受体 (PDGFRβ) 水平,采用了两种不同的测试方法 (基于抗体和基于aptamer).
主要成果:
- 这两种测定方法都证实了与没有认知波动和视觉幻觉的LBD患者的PDGF家族成员的血水平升高.
- 这些发现表明PDGF水平升高与LBD的特定发症状之间存在相关性.
结论:
- 血小板衍生生长因子 (PDGF) 信号似乎在LBD的发性症状中起作用.
- 结果表明PDGF信号传递和潜在的神经血管脱可能导致Lewy体疾病的认知波动和视觉幻觉.
相关概念视频
Parkinson's Disease: Treatment
972
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
972
Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K


